Spontaneous coronary artery dissection: Difference between revisions
No edit summary |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Spontaneous coronary artery dissection}} | {{Spontaneous coronary artery dissection}} | ||
{{CMG}}; {{AE}} {{NRM}}; {{AKK}} | {{CMG}}; {{AE}} {{NRM}}; {{AKK}}; | ||
{{SK}} SCAD | {{SK}} SCAD | ||
| Line 29: | Line 29: | ||
==Treatment== | ==Treatment== | ||
[[Spontaneous coronary artery dissection medical therapy|Medical Therapy]] | [[Spontaneous coronary artery dissection percutaneous coronary intervention|Percutaneous Coronary Intervention]] | [[Spontaneous coronary artery dissection surgery|Surgery]] | [[Spontaneous coronary artery dissection primary prevention|Primary Prevention]] | [[Spontaneous coronary artery dissection secondary prevention|Secondary Prevention]] | [[Spontaneous coronary artery dissection cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Spontaneous coronary artery dissection future or investigational therapies|Future or Investigational Therapies]] | [[Spontaneous coronary artery dissection treatment approach|Treatment Approach]] | [[Spontaneous coronary artery dissection medical therapy|Medical Therapy]] | [[Spontaneous coronary artery dissection percutaneous coronary intervention|Percutaneous Coronary Intervention]] | [[Spontaneous coronary artery dissection surgery|Surgery]] | [[Spontaneous coronary artery dissection primary prevention|Primary Prevention]] | [[Spontaneous coronary artery dissection secondary prevention|Secondary Prevention]] | [[Spontaneous coronary artery dissection cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Spontaneous coronary artery dissection future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Latest revision as of 12:54, 12 March 2022
|
Spontaneous Coronary Artery Dissection Microchapters |
|
Differentiating Spontaneous coronary artery dissection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Type 1 Type 2A Type 2B Type 3 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nate Michalak, B.A.; Arzu Kalayci, M.D. [2];
Synonyms and keywords: SCAD
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Any Disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Approach | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Angiography | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment Approach | Medical Therapy | Percutaneous Coronary Intervention | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
● Type 1:
Case 1 |
Case 2 |
Case 3 |
Case 4 |
Case 5 |
Case 6 |
Case 7
● Type 2A:
Case 1 |
Case 2 |
Case 3 |
Case 4 |
Case 5 |
Case 6
● Type 2B:
Case 1 |
Case 2 |
Case 3 |
Case 4
● Type 3:
Case 1 |
Case 2 |
Case 3 |
Case 4 |
Case 5 |
Case 6